About 200 reports

  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H2 2017
  • PTX-15 - DRUG PROFILE

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • HIV AIDS
  • Targeted Therapy
  • Transplantation
  • Vaccine
  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H1 2018
  • HEART TRANSPLANT REJECTION - PIPELINE BY NOXXON PHARMA AG, H1 2018

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • Target
  • Target

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION

  • Clinical Trial
  • Heart Transplant
  • HIV AIDS
  • Targeted Therapy
  • Vaccine

WE ARE FULFILLING OUR PROMISE TO MAKE SEQUENCING BASED INFORMATION AVAILABLE TO THE TRANSPLANT CLINIC, NOW ALSO FOR HEART TRANSPLANT PATIENTS. "

  • HIV AIDS
  • Orthopedics
  • Vaccine
  • Canada
  • North America
  • Human Immunodeficiency Virus (HIV) Infections (AIDS)
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2018

Report covers products from therapy areas Immunology, Oncology, Infectious Disease, Metabolic Disorders and Undisclosed which include indications Rheumatoid Arthritis, Autoimmune Disorders, Human Immunodeficiency Virus (HIV) Infections (AIDS), Ewing Sarcoma, Heart Transplant Reject

  • HIV AIDS
  • Hospital
  • Vaccine
  • World
  • Product Initiative

Food and Drug Administration (FDA), World Health Organization (WHO), GLOBOCAN, and various organ transplant registries.

  • Medical Device
  • Orthopedics
  • North America
  • United States
  • Zimmer Biomet Holdings, Inc.
  • DORMANT PRODUCTS, H2 2018 (CONTD..1), H2 2018

## ## ## Universities/ Institutes ## ## ## ## ## ## PRODUCTS UNDER DEVELOPMENT BY INDICATION NUMBER OF PRODUCTS UNDER DEVELOPMENT BY TOP ## INDICATIONS, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H## 2018 Indication Source: Global Markets Dire

  • HIV AIDS
  • Immunotherapy
  • Monoclonal Antibody
  • Targeted Therapy
  • Vaccine

The prominent features of this report are - ##.

  • HIV AIDS
  • Pharmaceutical
  • Targeted Therapy
  • Vaccine
  • World

USING POST-MORTEM BRAIN ANALYSIS, THE RESEARCHERS FOUND THAT THE TRANSPLANTED CELLS GRAFTED AND SURVIVED WELL IN THE TEST ANIMALS AFTER TRANSPLANTATION.

  • HIV AIDS
  • Orthopedics
  • Targeted Therapy
  • Vaccine
  • United States

CLINICAL TRIALS BY PHASE IN G## COUNTRIES LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINIC

  • HIV AIDS
  • Monoclonal Antibody
  • Targeted Therapy
  • Vaccine
  • Novartis AG

The prominent features of this report are - ##.

  • Pharmaceutical
  • Targeted Therapy
  • Vaccine
  • World
  • Conatus Pharmaceuticals Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Medical Biotechnology
  • Monoclonal Antibody
  • Targeted Therapy
  • Vaccine
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • HIV AIDS
  • Targeted Therapy
  • Therapy
  • Vaccine
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2019 (CONTD..4), H1 2019
  • DORMANT PRODUCTS, H1 2019 (CONTD..1), H1 2019

MP## is currently in phase ##.

  • Immunotherapy
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Vaccine
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Musculoskeletal Disorder
  • Neurological Disorder
  • Targeted Therapy
  • Therapy
  • Vaccine
  • DORMANT PRODUCTS, H2 2019 (CONTD..1), H2 2019

## Total ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT BY STAGE OF DEVELOPMENT, H## 2019 Stage of Development Number of Products Under Development PRODUCTS UNDER DEVELO

  • Immunotherapy
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Vaccine

Reddy' s Under Fasting Conditions GDCT## NCT##, BA## Immunology Heart Transplant Rejection, Kidney Transplant Rejection, Liver Transplant Rejection Completed Phase I Interventional tacrolimus Dr.

  • Clinical Trial
  • HIV AIDS
  • Targeted Therapy
  • Transplantation
  • Vaccine

GDCT ID is the unique ID of GlobalData' s Pharma Intelligence Center clinical trial database Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Biomarker(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor

  • HIV AIDS
  • Monoclonal Antibody
  • Orthopedics
  • Targeted Therapy
  • Vaccine
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • HIV AIDS
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Vaccine
  • DORMANT PRODUCTS, H2 2018 (CONTD..1), H2 2018

Significant survival advantages for the abatacept group were demonstrated at one-year post-transplant.

  • HIV AIDS
  • Immunotherapy
  • Targeted Therapy
  • Therapy
  • Vaccine

Hoffmann-La Roche Ltd ## ## ## ## ## ## Clinical Research and Biosciences India Private Limited (Inactive) ## ## ## ## ## ## ClinAssess GmbH ## ## ## ## ## ## Bavarian Nordic A/ S ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## APT

  • Medical Biotechnology
  • Pharmaceutical
  • Targeted Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Targeted Therapy
  • Therapy
  • Vaccine

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## Alexion Pharmaceuticals Inc ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## Cytokinetics Inc ## ## ## ## ## ## ## Quintiles IMS Holdings Inc ## ## ## ## ## ## ## CuraVac Inc ## ## ## ## ## ## ## CSL Ltd ##

  • Clinical Trial
  • Neurological Disorder
  • Targeted Therapy
  • Therapy
  • Vaccine

Reddy' s Under Fasting Conditions GDCT## NCT##, BA## Immunology Heart Transplant Rejection, Kidney Transplant Rejection, Liver Transplant Rejection Completed Phase I Interventional tacrolimus Dr.

  • Drug Development
  • HIV AIDS
  • Targeted Therapy
  • Vaccine
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Blood Disease
  • HIV AIDS
  • Monoclonal Antibody
  • Targeted Therapy
  • Vaccine
  • 5. All the trials included are unique trials.
  • Clinical Trial Profile Snapshots

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • HIV AIDS
  • Pharmaceutical
  • Targeted Therapy
  • Transplantation
  • Vaccine
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd arGEN-X BV ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Applied BioMath LLC ## ## ## ## ## Amgen Inc ## ## ## ## ## Almirall SA Source: GlobalData' s Pharma Intelligence C

  • Autoimmune Disease
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • HIV AIDS
  • Monoclonal Antibody
  • Targeted Therapy
  • Vaccine
  • World

An Open Labelled Randomized Everolimus Vs Calcineurin Inhibitors Multicenter Trial (CERTICOEUR) A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients.

  • Clinical Trial
  • HIV AIDS
  • Targeted Therapy
  • Therapy
  • Vaccine

## ## ## ## ## ## Pfizer Inc Stealth BioTherapeutics Inc Prolong Pharmaceuticals LLC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Minapharm Pharmaceuticals & Chemical Industries ## ## ## ## ## ## ## Merck & Co Inc ## ##

  • Drug Development
  • Targeted Therapy
  • Vaccine
  • World
  • Product Initiative